33 employees
Vesalius Therapeutics is focused on redefining the understanding and treatment of the diseases that drive ninety percent of human illness.
2019
$75M
from 1 investors over 1 rounds
Vesalius Therapeutics raised $75M on March 2, 2022
Investors: Flagship Ventures